![Ajan Reginald](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Ajan Reginald
Founder at
Cell Therapy Ltd.
Net worth: 2 M $ as of 31/12/2025
Profile
Ajan Trevor Reginald is the founder of Cell Therapy Ltd., established in 2009, serving as Chief Executive Officer & Executive Director.
Current jobs include Chairman at Oncogeni Ltd., Director at Desktop Genetics Ltd., and Managing Director, Secretary & Executive Director at Cardiogeni Plc since 2019.
Former jobs include Director-Business Development at Roche Pharmaceuticals, Inc., Chief Executive Director & Executive Director at Coiled Therapeutics Plc from 2022 to 2025, Global Head-Emerging Technologies at Roche Group, and Chief Operating & Technology Officer at Novacyt SAS. Education history includes graduate studies at the University of Oxford, undergraduate studies at the University of London, and an MBA from Kellogg School of Management.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
Celixir Plc
 Celixir Plc Pharmaceuticals: MajorHealth Technology Discovers and develops regenerative medicines to treat life threatening and life altering diseases 24.94% | 21/04/2026 | 22,223,711 ( 24.94% ) | 2 M $ | 31/12/2025 |
| 24/11/2025 | 380,508 ( 0.09% ) | 47 978 $ | 30/06/2026 |
Ajan Reginald active positions
| Companies | Position | Start |
|---|---|---|
Cell Therapy Ltd.
 Cell Therapy Ltd. BiotechnologyHealth Technology Operates as a clinical stage biotechnology firm | Founder | 01/01/2009 |
Celixir Plc
Celixir Plc Pharmaceuticals: MajorHealth Technology Discovers and develops regenerative medicines to treat life threatening and life altering diseases | Chief Executive Officer | 28/12/2016 |
Desktop Genetics Ltd.
 Desktop Genetics Ltd. Packaged SoftwareTechnology Services Develops software tools to enable literal desktop genetics | Director/Board Member | - |
Oncogeni Ltd.
 Oncogeni Ltd. BiotechnologyHealth Technology Operates as biotechnology company | Chairman | - |
Former positions of Ajan Reginald
| Companies | Position | End |
|---|---|---|
| ROQT THER | Chief Executive Officer | 17/03/2025 |
| NOVACYT | Chief Operating Officer | - |
Roche Group
 Roche Group Real Estate DevelopmentFinance Manages real estate properties | Corporate Officer/Principal | - |
Roche Pharmaceuticals, Inc.
 Roche Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Provides research and development services | Corporate Officer/Principal | - |
Training of Ajan Reginald
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
12
1st degree connections
11
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 11 |
|---|---|
Roche Pharmaceuticals, Inc.
Roche Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Provides research and development services | Commercial Services |
University of Oxford
 University of Oxford Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Roche Group
Roche Group Real Estate DevelopmentFinance Manages real estate properties | Finance |
University of London
 University of London Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Novacyt SAS
 Novacyt SAS Medical SpecialtiesHealth Technology Designs, develops and markets molecular real-time PCR testing devices and reagents in the areas of infectious diseases | Health Technology |
Cell Therapy Ltd.
Cell Therapy Ltd. BiotechnologyHealth Technology Operates as a clinical stage biotechnology firm | Health Technology |
Kellogg School of Management
 Kellogg School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Desktop Genetics Ltd.
Desktop Genetics Ltd. Packaged SoftwareTechnology Services Develops software tools to enable literal desktop genetics | Technology Services |
Celixir Plc
Celixir Plc Pharmaceuticals: MajorHealth Technology Discovers and develops regenerative medicines to treat life threatening and life altering diseases | Health Technology |
Roquefort Therapeutics Plc
 Roquefort Therapeutics Plc Pharmaceuticals: MajorHealth Technology Develops pre-clinical next generation medicines for cancer treatment | Health Technology |
Oncogeni Ltd.
Oncogeni Ltd. BiotechnologyHealth Technology Operates as biotechnology company | Health Technology |
- Stock Market
- Insiders
- Ajan Reginald
Choose MarketScreener 
